bluebird bio, Inc. Insider Trading for February 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in bluebird bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in bluebird bio, Inc. for February 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 2019 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Option Exercise | M | 50.51 | 4,000 | 202,040 | 9,500 | |
| Feb 27 2019 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Option Exercise | M | 22.53 | 2,248 | 50,647 | 0 | |
| Feb 27 2019 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 151.41 | 525 | 79,491 | 26,444 | 27 K to 26.4 K (-1.95 %) |
| Feb 27 2019 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 150.13 | 5,723 | 859,207 | 26,969 | 32.7 K to 27 K (-17.51 %) |
| Feb 27 2019 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Buy | M | 50.51 | 4,000 | 202,040 | 32,692 | 28.7 K to 32.7 K (+13.94 %) |
| Feb 27 2019 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Buy | M | 22.53 | 2,248 | 50,647 | 28,692 | 26.4 K to 28.7 K (+8.50 %) |
| Feb 27 2019 | BLUE | bluebird bio, Inc. | WENTWORTH KORY JAMES | Principal Accountin ... | Sell | S | 150.00 | 208 | 31,201 | 6,746 | 7 K to 6.7 K (-2.99 %) |
| Feb 12 2019 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial and | Option Exercise | D | 24.47 | 1,500 | 36,705 | 16,021 | |
| Feb 12 2019 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial and | Sell | S | 131.87 | 500 | 65,933 | 40,921 | 41.4 K to 40.9 K (-1.21 %) |
| Feb 12 2019 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial and | Sell | S | 131.00 | 1,000 | 130,995 | 41,421 | 42.4 K to 41.4 K (-2.36 %) |
| Feb 12 2019 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial and | Buy | M | 24.47 | 1,500 | 36,705 | 42,421 | 40.9 K to 42.4 K (+3.67 %) |
| Feb 07 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 75.60 | 700 | 52,920 | 29,200 | |
| Feb 07 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 600 | 30,306 | 12,800 | |
| Feb 07 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 139.45 | 700 | 97,616 | 33,092 | 33.8 K to 33.1 K (-2.07 %) |
| Feb 07 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 137.72 | 500 | 68,859 | 33,792 | 34.3 K to 33.8 K (-1.46 %) |
| Feb 07 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 136.51 | 600 | 81,908 | 34,292 | 34.9 K to 34.3 K (-1.72 %) |
| Feb 07 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 75.60 | 700 | 52,920 | 34,892 | 34.2 K to 34.9 K (+2.05 %) |
| Feb 07 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 50.51 | 600 | 30,306 | 34,192 | 33.6 K to 34.2 K (+1.79 %) |
| Feb 05 2019 | BLUE | bluebird bio, Inc. | WENTWORTH KORY JAMES | Principal Accountin ... | Option Exercise | A | 134.63 | 10,000 | 1,346,300 | 10,000 | |
| Feb 05 2019 | BLUE | bluebird bio, Inc. | WENTWORTH KORY JAMES | Principal Accountin ... | Grant | A | 0.00 | 2,500 | 0 | 6,954 | 4.5 K to 7 K (+56.13 %) |
| Feb 05 2019 | BLUE | bluebird bio, Inc. | FINGER ALISON CECILY | Chief Commercial Of ... | Option Exercise | A | 134.63 | 20,000 | 2,692,600 | 20,000 | |
| Feb 05 2019 | BLUE | bluebird bio, Inc. | FINGER ALISON CECILY | Chief Commercial Of ... | Grant | A | 0.00 | 5,000 | 0 | 19,681 | 14.7 K to 19.7 K (+34.06 %) |
| Feb 05 2019 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Option Exercise | A | 134.63 | 25,000 | 3,365,750 | 25,000 | |
| Feb 05 2019 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Grant | A | 0.00 | 6,250 | 0 | 26,444 | 20.2 K to 26.4 K (+30.95 %) |
| Feb 05 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | A | 134.63 | 27,000 | 3,635,010 | 27,000 | |
| Feb 05 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Grant | A | 0.00 | 6,750 | 0 | 33,592 | 26.8 K to 33.6 K (+25.15 %) |
| Feb 05 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 50.51 | 1,355 | 68,441 | 37,045 | |
| Feb 05 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 24.47 | 3,555 | 86,991 | 3,610 | |
| Feb 05 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | A | 134.63 | 37,500 | 5,048,625 | 37,500 | |
| Feb 05 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 135.10 | 1,200 | 162,123 | 31,616 | 32.8 K to 31.6 K (-3.66 %) |
| Feb 05 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 134.22 | 3,110 | 417,415 | 32,816 | 35.9 K to 32.8 K (-8.66 %) |
| Feb 05 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 133.13 | 600 | 79,879 | 35,926 | 36.5 K to 35.9 K (-1.64 %) |
| Feb 05 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 50.51 | 1,355 | 68,441 | 36,526 | 35.2 K to 36.5 K (+3.85 %) |
| Feb 05 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 24.47 | 3,555 | 86,991 | 35,171 | 31.6 K to 35.2 K (+11.24 %) |
| Feb 05 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Grant | A | 0.00 | 9,375 | 0 | 31,616 | 22.2 K to 31.6 K (+42.15 %) |
| Feb 05 2019 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | A | 134.63 | 33,750 | 4,543,763 | 33,750 | |
| Feb 05 2019 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Grant | A | 0.00 | 8,438 | 0 | 40,921 | 32.5 K to 40.9 K (+25.98 %) |
| Feb 05 2019 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Option Exercise | A | 134.63 | 100,000 | 13,463,000 | 100,000 | |
| Feb 05 2019 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Grant | A | 0.00 | 25,000 | 0 | 218,203 | 193.2 K to 218.2 K (+12.94 %) |